Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lexmark International Inc (NYSE:LXK): Are Hedge Funds Right About This Stock?

Lexmark International Inc (NYSE:LXK) was in 18 hedge funds’ portfolio at the end of December. LXK has experienced a decrease in activity from the world’s largest hedge funds lately. There were 19 hedge funds in our database with LXK holdings at the end of the previous quarter.

Lexmark International Inc (NYSE:LXK)

In today’s marketplace, there are dozens of metrics market participants can use to monitor stocks. A pair of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite investment managers can outpace the broader indices by a significant amount (see just how much).

Equally as beneficial, bullish insider trading activity is a second way to break down the marketplace. Obviously, there are plenty of stimuli for an insider to drop shares of his or her company, but just one, very clear reason why they would behave bullishly. Various empirical studies have demonstrated the valuable potential of this strategy if investors know what to do (learn more here).

Keeping this in mind, it’s important to take a gander at the latest action regarding Lexmark International Inc (NYSE:LXK).

How have hedgies been trading Lexmark International Inc (NYSE:LXK)?

In preparation for this year, a total of 18 of the hedge funds we track were bullish in this stock, a change of -5% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, David Cohen and Harold Levy’s Iridian Asset Management had the most valuable position in Lexmark International Inc (NYSE:LXK), worth close to $80 million, accounting for 1.3% of its total 13F portfolio. The second largest stake is held by First Eagle Investment Management, managed by Jean-Marie Eveillard, which held a $20 million position; 0.4% of its 13F portfolio is allocated to the company. Other hedgies that hold long positions include Martin Whitman’s Third Avenue Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital and Cliff Asness’s AQR Capital Management.

Because Lexmark International Inc (NYSE:LXK) has witnessed falling interest from the entirety of the hedge funds we track, it’s safe to say that there was a specific group of money managers that elected to cut their positions entirely last quarter. Intriguingly, David Harding’s Winton Capital Management said goodbye to the biggest stake of the 450+ funds we key on, valued at about $7 million in stock.. Dmitry Balyasny’s fund, Balyasny Asset Management, also sold off its stock, about $6 million worth. These bearish behaviors are intriguing to say the least, as total hedge fund interest dropped by 1 funds last quarter.

What have insiders been doing with Lexmark International Inc (NYSE:LXK)?

Insider buying is at its handiest when the company in question has experienced transactions within the past half-year. Over the latest half-year time frame, Lexmark International Inc (NYSE:LXK) has experienced 1 unique insiders buying, and 8 insider sales (see the details of insider trades here).

With the results shown by Insider Monkey’s tactics, retail investors must always pay attention to hedge fund and insider trading activity, and Lexmark International Inc (NYSE:LXK) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!